ID   2ABB_HUMAN              Reviewed;         443 AA.
AC   Q00005; A6NEJ2; A8K102; B3KPD0; B7Z2F2; B7Z304; D3DQF7; D3DQF8;
AC   G3V149;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   12-APR-2017, entry version 175.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform;
DE   AltName: Full=PP2A subunit B isoform B55-beta;
DE   AltName: Full=PP2A subunit B isoform PR55-beta;
DE   AltName: Full=PP2A subunit B isoform R2-beta;
DE   AltName: Full=PP2A subunit B isoform beta;
GN   Name=PPP2R2B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=1849734; DOI=10.1021/bi00229a001;
RA   Mayer R.E., Hendrix P., Cron P., Matthies R., Stone S.R., Goris J.,
RA   Merlevede W., Hofsteenge J., Hemmings B.A.;
RT   "Structure of the 55-kDa regulatory subunit of protein phosphatase 2A:
RT   evidence for a neuronal-specific isoform.";
RL   Biochemistry 30:3589-3597(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 14-433 (ISOFORM 7).
RC   TISSUE=Brain, and Corpus callosum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-131 (ISOFORM 6).
RC   TISSUE=Brain, and Hypothalamus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-197 (ISOFORM 2).
RA   Strausberg R.L.;
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   INVOLVEMENT IN SCA12.
RX   PubMed=10581021; DOI=10.1038/70493;
RA   Holmes S.E., O'Hearn E.E., McInnis M.G., Gorelick-Feldman D.A.,
RA   Kleiderlein J.J., Callahan C., Kwak N.G., Ingersoll-Ashworth R.G.,
RA   Sherr M., Sumner A.J., Sharp A.H., Ananth U., Seltzer W.K., Boss M.A.,
RA   Vieria-Saecker A.-M., Epplen J.T., Riess O., Ross C.A., Margolis R.L.;
RT   "Expansion of a novel CAG trinucleotide repeat in the 5' region of
RT   PPP2R2B is associated with SCA12.";
RL   Nat. Genet. 23:391-392(1999).
RN   [8]
RP   INTERACTION WITH IER5.
RX   PubMed=25816751; DOI=10.1016/j.febslet.2015.03.019;
RA   Ishikawa Y., Kawabata S., Sakurai H.;
RT   "HSF1 transcriptional activity is modulated by IER5 and PP2A/B55.";
RL   FEBS Lett. 589:1150-1155(2015).
RN   [9]
RP   INTERACTION WITH IER5.
RX   PubMed=26496226; DOI=10.1016/j.febslet.2015.10.013;
RA   Kawabata S., Ishita Y., Ishikawa Y., Sakurai H.;
RT   "Immediate-early response 5 (IER5) interacts with protein phosphatase
RT   2A and regulates the phosphorylation of ribosomal protein S6 kinase
RT   and heat shock factor 1.";
RL   FEBS Lett. 589:3679-3685(2015).
CC   -!- FUNCTION: The B regulatory subunit might modulate substrate
CC       selectivity and catalytic activity, and also might direct the
CC       localization of the catalytic enzyme to a particular subcellular
CC       compartment. Within the PP2A holoenzyme complex, isoform 2 is
CC       required to promote proapoptotic activity (By similarity). Isoform
CC       2 regulates neuronal survival through the mitochondrial fission
CC       and fusion balance (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: PP2A consists of a common heterodimeric core enzyme,
CC       composed of a 36 kDa catalytic subunit (subunit C) and a 65 kDa
CC       constant regulatory subunit (PR65 or subunit A), that associates
CC       with a variety of regulatory subunits. Proteins that associate
CC       with the core dimer include three families of regulatory subunits
CC       B (the R2/B/PR55/B55, R3/B''/PR72/PR130/PR59 and R5/B'/B56
CC       families), the 48 kDa variable regulatory subunit, viral proteins,
CC       and cell signaling molecules (By similarity). Interacts with
CC       TOMM22 (By similarity). Interacts with IER5 (via N- and C-terminal
CC       regions) (PubMed:25816751, PubMed:26496226). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P36877, ECO:0000269|PubMed:25816751,
CC       ECO:0000269|PubMed:26496226}.
CC   -!- INTERACTION:
CC       O15530:PDPK1; NbExp=8; IntAct=EBI-1052159, EBI-717097;
CC       P30153:PPP2R1A; NbExp=6; IntAct=EBI-1052159, EBI-302388;
CC       P23443:RPS6KB1; NbExp=2; IntAct=EBI-1052159, EBI-1775921;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cytoplasm {ECO:0000250}.
CC       Cytoplasm, cytoskeleton {ECO:0000250}. Membrane {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm {ECO:0000250}.
CC       Mitochondrion {ECO:0000250}. Mitochondrion outer membrane
CC       {ECO:0000250}. Note=Under basal conditions, localizes to both
CC       cytosolic and mitochondrial compartments. Relocalizes from the
CC       cytosolic to the mitochondrial compartment during apoptosis. Its
CC       targeting to the outer mitochondrial membrane (OMM) involves an
CC       association with import receptors of the TOM complex and is
CC       required to promote proapoptotic activity (By similarity).
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1; Synonyms=Bbeta, Bbeta1;
CC         IsoId=Q00005-1; Sequence=Displayed;
CC         Note=Conserved additional ATG codons are found 5' of the
CC         putative initiator codon in transcripts supporting isoform 1.
CC         They may initiate the translation of upstream short open reading
CC         frames altering the expression of that isoform as described in
CC         PubMed:1849734.;
CC       Name=2; Synonyms=Bbeta2;
CC         IsoId=Q00005-2; Sequence=VSP_037976;
CC         Note=Contains a cryptic mitochondrial transit peptide at
CC         positions 1-26. {ECO:0000250};
CC       Name=3;
CC         IsoId=Q00005-3; Sequence=VSP_037977;
CC       Name=4;
CC         IsoId=Q00005-4; Sequence=VSP_037978;
CC       Name=5;
CC         IsoId=Q00005-5; Sequence=VSP_037979;
CC       Name=6;
CC         IsoId=Q00005-6; Sequence=VSP_044923;
CC       Name=7;
CC         IsoId=Q00005-7; Sequence=VSP_045748;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Brain.
CC   -!- DOMAIN: The N-terminal 26 residues of isoform 2 constitute a
CC       cryptic mitochondrial matrix import signal with critical basic and
CC       hydrophobic residues, that is necessary and sufficient for
CC       targeting the PP2A holoenzyme to the outer mitochondrial membrane
CC       (OMM) and does not affect holoenzyme formation or catalytic
CC       activity. {ECO:0000250}.
CC   -!- DOMAIN: The last WD repeat of isoform 2 constitutes a
CC       mitochondrial stop-transfer domain that confers resistance to the
CC       unfolding step process required for import and therefore prevents
CC       PPP2R2B matrix translocation and signal sequence cleavage.
CC       {ECO:0000250}.
CC   -!- DISEASE: Spinocerebellar ataxia 12 (SCA12) [MIM:604326]:
CC       Spinocerebellar ataxia is a clinically and genetically
CC       heterogeneous group of cerebellar disorders. Patients show
CC       progressive incoordination of gait and often poor coordination of
CC       hands, speech and eye movements, due to degeneration of the
CC       cerebellum with variable involvement of the brainstem and spinal
CC       cord. SCA12 is an autosomal dominant cerebellar ataxia (ADCA).
CC       {ECO:0000269|PubMed:10581021}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the phosphatase 2A regulatory subunit B
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH31790.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAG51642.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAG51642.1; Type=Erroneous termination; Positions=116; Note=Translated as Lys.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M64930; AAA36493.1; -; mRNA.
DR   EMBL; AK056192; BAG51642.1; ALT_SEQ; mRNA.
DR   EMBL; AK289717; BAF82406.1; -; mRNA.
DR   EMBL; AK294659; BAH11838.1; -; mRNA.
DR   EMBL; AK295347; BAH12040.1; -; mRNA.
DR   EMBL; AC008728; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC009186; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010251; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011386; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011357; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091919; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091924; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61829.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61831.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61832.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61833.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61834.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61835.1; -; Genomic_DNA.
DR   EMBL; BC031790; AAH31790.1; ALT_INIT; mRNA.
DR   EMBL; BI490027; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BI669304; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS4283.1; -. [Q00005-2]
DR   CCDS; CCDS4284.2; -. [Q00005-5]
DR   CCDS; CCDS43380.1; -. [Q00005-6]
DR   CCDS; CCDS64281.1; -. [Q00005-4]
DR   CCDS; CCDS64282.1; -. [Q00005-3]
DR   PIR; B38351; B38351.
DR   RefSeq; NP_001258828.1; NM_001271899.1. [Q00005-3]
DR   RefSeq; NP_001258829.1; NM_001271900.1. [Q00005-4]
DR   RefSeq; NP_001258877.1; NM_001271948.1. [Q00005-6]
DR   RefSeq; NP_858060.2; NM_181674.2. [Q00005-5]
DR   RefSeq; NP_858061.2; NM_181675.3. [Q00005-7]
DR   RefSeq; NP_858062.1; NM_181676.2. [Q00005-2]
DR   RefSeq; NP_858063.1; NM_181677.2.
DR   RefSeq; NP_858064.1; NM_181678.2. [Q00005-6]
DR   UniGene; Hs.627618; -.
DR   UniGene; Hs.655213; -.
DR   ProteinModelPortal; Q00005; -.
DR   SMR; Q00005; -.
DR   BioGrid; 111513; 47.
DR   IntAct; Q00005; 169.
DR   MINT; MINT-6631022; -.
DR   STRING; 9606.ENSP00000336591; -.
DR   iPTMnet; Q00005; -.
DR   PhosphoSitePlus; Q00005; -.
DR   BioMuta; PPP2R2B; -.
DR   DMDM; 231446; -.
DR   MaxQB; Q00005; -.
DR   PaxDb; Q00005; -.
DR   PeptideAtlas; Q00005; -.
DR   PRIDE; Q00005; -.
DR   DNASU; 5521; -.
DR   Ensembl; ENST00000336640; ENSP00000336591; ENSG00000156475. [Q00005-2]
DR   Ensembl; ENST00000394409; ENSP00000377931; ENSG00000156475. [Q00005-1]
DR   Ensembl; ENST00000394411; ENSP00000377933; ENSG00000156475. [Q00005-1]
DR   Ensembl; ENST00000394413; ENSP00000377935; ENSG00000156475. [Q00005-4]
DR   Ensembl; ENST00000394414; ENSP00000377936; ENSG00000156475. [Q00005-5]
DR   Ensembl; ENST00000453001; ENSP00000398779; ENSG00000156475. [Q00005-6]
DR   Ensembl; ENST00000504198; ENSP00000421396; ENSG00000156475. [Q00005-3]
DR   Ensembl; ENST00000508545; ENSP00000431320; ENSG00000156475. [Q00005-6]
DR   GeneID; 5521; -.
DR   KEGG; hsa:5521; -.
DR   UCSC; uc003loe.6; human. [Q00005-1]
DR   CTD; 5521; -.
DR   DisGeNET; 5521; -.
DR   GeneCards; PPP2R2B; -.
DR   GeneReviews; PPP2R2B; -.
DR   HGNC; HGNC:9305; PPP2R2B.
DR   HPA; HPA038118; -.
DR   HPA; HPA042122; -.
DR   HPA; HPA042770; -.
DR   MalaCards; PPP2R2B; -.
DR   MIM; 604325; gene.
DR   MIM; 604326; phenotype.
DR   neXtProt; NX_Q00005; -.
DR   OpenTargets; ENSG00000156475; -.
DR   Orphanet; 98762; Spinocerebellar ataxia type 12.
DR   PharmGKB; PA33669; -.
DR   eggNOG; KOG1354; Eukaryota.
DR   eggNOG; COG5170; LUCA.
DR   GeneTree; ENSGT00390000006311; -.
DR   HOVERGEN; HBG000012; -.
DR   InParanoid; Q00005; -.
DR   KO; K04354; -.
DR   OMA; PIPPRTF; -.
DR   OrthoDB; EOG091G09BB; -.
DR   PhylomeDB; Q00005; -.
DR   TreeFam; TF105553; -.
DR   SignaLink; Q00005; -.
DR   SIGNOR; Q00005; -.
DR   ChiTaRS; PPP2R2B; human.
DR   GeneWiki; PPP2R2B; -.
DR   GenomeRNAi; 5521; -.
DR   PRO; PR:Q00005; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000156475; -.
DR   CleanEx; HS_PPP2R2B; -.
DR   ExpressionAtlas; Q00005; baseline and differential.
DR   Genevisible; Q00005; HS.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; IBA:GO_Central.
DR   GO; GO:0019888; F:protein phosphatase regulator activity; IBA:GO_Central.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0032502; P:developmental process; IBA:GO_Central.
DR   GO; GO:0000278; P:mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0070262; P:peptidyl-serine dephosphorylation; IBA:GO_Central.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR000009; PP2A_PR55.
DR   InterPro; IPR018067; PP2A_PR55_CS.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   PANTHER; PTHR11871; PTHR11871; 1.
DR   PIRSF; PIRSF037309; PP2A_PR55; 1.
DR   PRINTS; PR00600; PP2APR55.
DR   SMART; SM00320; WD40; 6.
DR   SUPFAM; SSF50978; SSF50978; 3.
DR   PROSITE; PS01024; PR55_1; 1.
DR   PROSITE; PS01025; PR55_2; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Membrane; Mitochondrion; Mitochondrion outer membrane;
KW   Neurodegeneration; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Spinocerebellar ataxia; WD repeat.
FT   CHAIN         1    443       Serine/threonine-protein phosphatase 2A
FT                                55 kDa regulatory subunit B beta isoform.
FT                                /FTId=PRO_0000071421.
FT   REPEAT       22     61       WD 1.
FT   REPEAT       87    128       WD 2.
FT   REPEAT      171    209       WD 3.
FT   REPEAT      220    260       WD 4.
FT   REPEAT      279    317       WD 5.
FT   REPEAT      334    375       WD 6.
FT   REPEAT      410    442       WD 7.
FT   MOD_RES     275    275       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P36877}.
FT   MOD_RES     295    295       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P36877}.
FT   MOD_RES     298    298       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P36877}.
FT   VAR_SEQ       1     23       MEEDIDTRKINNSFLRDHSYATE -> MNYPDENTYGNK
FT                                (in isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044923.
FT   VAR_SEQ       1     21       MEEDIDTRKINNSFLRDHSYA -> MKCFSRYLPYIFRPPN
FT                                TILSSSCH (in isoform 2).
FT                                {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_037976.
FT   VAR_SEQ       1     21       MEEDIDTRKINNSFLRDHSYA -> MIPGIGTLTQDTLWCF
FT                                SQVKGTIEIGT (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_037977.
FT   VAR_SEQ       1      1       M -> MVLQPSERHYRDWNHRRLGPWCSPTGSPAPLSCETG
FT                                CGEGSWILVCRLLVPTQVSLLSM (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_037978.
FT   VAR_SEQ       1      1       M -> MLLSLPALHLQTSEHHPFFQLPHRRLGPWCSPTGSP
FT                                APLSCETGCGEGSWILVCRLLVPTQVSLLSM (in
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037979.
FT   VAR_SEQ       1      1       M -> MHQPPPASCSSSSSSSSSSCECARVGVRVSALAPAA
FT                                APCPAPRQLPYPRLPEPPSRGTSTLIPARLGPWCSPTGSPA
FT                                PLSCETGCGEGSWILVCRLLVPTQVSLLSM (in
FT                                isoform 7).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045748.
FT   VARIANT      36     36       G -> V (in dbSNP:rs11547494).
FT                                /FTId=VAR_051738.
FT   CONFLICT     22     22       T -> A (in Ref. 2; BAH11838).
FT                                {ECO:0000305}.
FT   CONFLICT     62     62       H -> N (in Ref. 5; BI669304).
FT                                {ECO:0000305}.
FT   CONFLICT    109    109       S -> F (in Ref. 2; BAH12040).
FT                                {ECO:0000305}.
FT   CONFLICT    163    163       T -> S (in Ref. 6; BI490027).
FT                                {ECO:0000305}.
FT   CONFLICT    164    164       P -> S (in Ref. 2; BAF82406).
FT                                {ECO:0000305}.
FT   CONFLICT    292    292       S -> R (in Ref. 2; BAH12040).
FT                                {ECO:0000305}.
SQ   SEQUENCE   443 AA;  51710 MW;  C383C834B2852B8F CRC64;
     MEEDIDTRKI NNSFLRDHSY ATEADIISTV EFNHTGELLA TGDKGGRVVI FQREQESKNQ
     VHRRGEYNVY STFQSHEPEF DYLKSLEIEE KINKIRWLPQ QNAAYFLLST NDKTVKLWKV
     SERDKRPEGY NLKDEEGRLR DPATITTLRV PVLRPMDLMV EATPRRVFAN AHTYHINSIS
     VNSDYETYMS ADDLRINLWN FEITNQSFNI VDIKPANMEE LTEVITAAEF HPHHCNTFVY
     SSSKGTIRLC DMRASALCDR HTKFFEEPED PSNRSFFSEI ISSISDVKFS HSGRYIMTRD
     YLTVKVWDLN MENRPIETYQ VHDYLRSKLC SLYENDCIFD KFECVWNGSD SVIMTGSYNN
     FFRMFDRNTK RDVTLEASRE NSKPRAILKP RKVCVGGKRR KDEISVDSLD FSKKILHTAW
     HPSENIIAVA ATNNLYIFQD KVN
//
